Social Network
CDC committee votes to resume Johnson & Johnson COVID-19 vaccine despite possible blood clot link
April 24 2021, 08:00
A Centers for Disease Control and Prevention (CDC) advisory committee is recommending that the Johnson & Johnson COVID-19 vaccine resume rollout, but include new language on the product’s emergency use authorization (EUA) warning remote risks of serious blood clots.